Stephen Barnes Selected Research

immunoglobulin M receptor

11/2011

Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen Barnes Research Topics

Disease

21	Neoplasms (Cancer) 01/2021 - 11/2003
15	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2003
9	Inflammation (Inflammations) 05/2020 - 12/2003
6	Body Weight (Weight, Body) 01/2018 - 06/2003
4	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 01/2010
4	Carcinogenesis 01/2021 - 12/2004
4	Postmenopausal Osteoporosis 09/2015 - 10/2009
3	Meibomian Gland Dysfunction 01/2022 - 01/2021
3	Infections 01/2019 - 01/2017
3	Asthma (Bronchial Asthma) 01/2018 - 12/2003
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2016 - 08/2009
3	Neoplasm Metastasis (Metastasis) 01/2011 - 03/2010
3	Alzheimer Disease (Alzheimer's Disease) 09/2007 - 12/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2005
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 11/2011
2	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 01/2016
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2021 - 06/2015
2	Neurofibrosarcoma (MPNST) 01/2021 - 06/2015
2	Idiopathic Pulmonary Fibrosis 11/2019 - 01/2018
2	Alexander Disease (Alexander's Disease) 10/2019 - 01/2016
2	Cataract (Cataracts) 01/2017 - 02/2011
2	Septic Shock (Toxic Shock Syndrome) 02/2016 - 09/2010
2	Glomerulonephritis 11/2015 - 01/2006
2	Mitochondrial Diseases (Mitochondrial Disease) 09/2013 - 08/2004
2	Hypertrophy 01/2013 - 12/2009
2	Cognitive Dysfunction 07/2010 - 03/2006
2	Stroke (Strokes) 01/2010 - 08/2009
2	Arthritis (Polyarthritis) 01/2006 - 09/2005
1	Prediabetic State (Prediabetes) 01/2022
1	Dysbiosis 01/2021
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021
1	Obesity 01/2021
1	Nervous System Neoplasms (Neoplasms, Nervous System) 01/2021
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2019
1	Abscess 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2019

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
16	IsoflavonesIBA 01/2017 - 06/2003
8	GenisteinIBA 01/2017 - 01/2003
7	LipidsIBA 01/2021 - 11/2015
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2005
5	PolyphenolsIBA 01/2020 - 11/2003
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 12/2009
4	Estrogens (Estrogen)FDA Link 01/2021 - 07/2005
4	EnzymesIBA 04/2016 - 12/2003
4	CholesterolIBA 11/2015 - 08/2009
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2006
3	Estrogen ReceptorsIBA 01/2020 - 07/2010
3	SteroidsIBA 01/2017 - 03/2010
3	Carrier Proteins (Binding Protein)IBA 11/2015 - 01/2003
3	EquolIBA 09/2015 - 07/2010
3	Phytoestrogens (Phytoestrogen)IBA 08/2011 - 12/2009
2	Tryptophan (L-Tryptophan)FDA Link 01/2021 - 01/2017
2	Neurofibromin 1 (Neurofibromin)IBA 01/2021 - 06/2015
2	ras ProteinsIBA 01/2021 - 06/2015
2	TeaIBA 01/2020 - 12/2004
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2017 - 02/2015
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2017 - 01/2012
2	QuercetinIBA 09/2016 - 01/2013
2	GlucocorticoidsIBA 04/2016 - 12/2003
2	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 02/2016 - 09/2007
2	LigandsIBA 11/2015 - 09/2005
2	Apolipoproteins E (ApoE)IBA 11/2015 - 01/2013
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2015 - 01/2010
2	Heme (Haem)IBA 02/2015 - 07/2012
2	CarcinogensIBA 01/2014 - 12/2004
2	Blood Glucose (Blood Sugar)IBA 09/2013 - 11/2005
2	Oxidants (Oxidizing Agents)IBA 09/2013 - 02/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2011 - 02/2003
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2011 - 02/2003
2	ProteomeIBA 01/2011 - 11/2008
2	AntioxidantsIBA 07/2010 - 03/2010
2	daidzeinIBA 01/2010 - 06/2005
2	Grape Seed ExtractIBA 03/2009 - 12/2004
2	Peptides (Polypeptides)IBA 11/2006 - 01/2003
2	Biological ProductsIBA 09/2005 - 12/2003
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2003 - 02/2003
1	IndicanIBA 01/2022
1	Fc Receptors (Fc Receptor)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	EstersIBA 01/2022
1	phenylacetylglutamineIBA 01/2022
1	AntigensIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Cholesterol Esters (Cholesteryl Esters)IBA 01/2022
1	NAD (NADH)IBA 12/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	Dietary Fiber FDA Link 01/2021
1	High Fructose Corn SyrupIBA 01/2021
1	GlucuronidaseIBA 01/2021
1	Volatile Fatty AcidsIBA 01/2020
1	Glial Fibrillary Acidic ProteinIBA 10/2019
1	CarbonIBA 01/2019
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2019

Therapy/Procedure

6	Therapeutics 05/2020 - 11/2002
2	Ketogenic Diet 05/2020 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2017 - 01/2017
2	Chemoprevention 11/2007 - 12/2004
1	Ligation 01/2022